On Monday, Longboard Pharmaceuticals Inc (LBPH) stock saw a decline, ending the day at $59.5 which represents a decrease of $-0.19 or -0.32% from the prior close of $59.69. The stock opened at $59.66 ...

On Friday, Longboard Pharmaceuticals Inc (LBPH) stock saw a decline, ending the day at $59.69 which represents a decrease of $-0.03 or -0.05% from the prior close of $59.72. The stock opened at $59.95 ...

(Bloomberg) -- H. Lundbeck A/S agreed to acquire Longboard Pharmaceuticals Inc in a $2.6 billion deal that boosts its drug pipeline for serious brain diseases. The Danish pharmaceutical company is ...

Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Free Report) have earned an average rating of “Hold” from the nine ratings firms that are covering the company, MarketBeat.com reports.

Shares of Longboard Pharmaceuticals Inc. are surging more than 51% Monday, boosted by H. Lundbeck’s $2.6 billion deal to acquire the California-based clinical-stage biopharmaceutical company.

Pre-earnings options volume in Longboard Pharmaceuticals ( LBPH) Inc is normal with calls leading puts 5:2. Implied volatility suggests the market is anticipating a move near 0.8%, or 45c, after ...

Shares of Longboard Pharmaceuticals, Inc. LBPH rose sharply in today's pre-market trading. Lundbeck agreed to acquire Longboard Pharmaceuticals in a transaction valued at approximately $2.6 ...

On Monday, Longboard Pharmaceuticals Inc (NASDAQ: LBPH) saw its price target increased to $36.00 from $30.00, while its stock rating remained a Buy, as announced by a B.Riley ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...